Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence

Current drug targets

Volumn 14, Issue 7, 2013, Pages 768-776

  Le Foll, Bernard ^a   Di Ciano, Patricia ^a   Panlilio, Leigh V ^a   Goldberg, Steven R ^a   Ciccocioppo, Roberto ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGONISTS; ANIMAL; DRUG DESIGN; DRUG SCREENING; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SECONDARY PREVENTION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

ANIMALS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; PPAR ALPHA; PPAR GAMMA; SECONDARY PREVENTION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84882456322     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Review

References (0)